Foyez Ahmmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Foyez Ahmmed has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Mohammod Mahmudur Rahman
Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS 66160, USA
35 shared publications - Amrita Mitra
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, USA
34 shared publications - Andrew K. Godwin
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, USA
34 shared publications - Jared Sipes
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA; Bioengineering Program, The University of Kansas, Lawrence, KS, 64111, USA
34 shared publications - Sagar Rayamajhi
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA
34 shared publications - Angela Russo
University of Illinois at Chicago, Illinois, Chicago, United States
32 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0358877
Exploring the association between low birth weight and different forms of child malnutrition: A multi-country propensity score matching analysis in South Asia
This study investigated the association between low birth weight (LBW) and various forms of child malnutrition across five South Asian countries (Bangladesh, India, Pakistan, Nepal, and the Maldives). Data from the most recent demographic and health surveys were analyzed. Propensity score matching was applied to evaluate the association between LBW and five forms of child malnutrition: stunting, wasting, underweight, at least one form of child malnutrition (AOFOCM), and multiple concurrent forms of child malnutrition (MCFOCM). Subgroup analyses were performed to assess variability in effects across the countries studied. Analysis of 147,332 complete cases revealed an overall LBW prevalence of 16.23%, with country-specific prevalences of 13.67% (Bangladesh), 16.32% (India), 18.97% (Pakistan), 11.94% (Nepal), and 12.86% (Maldives). Regression analyses of matched samples revealed significant associations between LBW and all five forms of malnutrition. Subgroup analyses also revealed a significant association between LBW and all five forms of malnutrition across the five countries, with the exception of wasting, for which no statistically significant association was observed in Bangladesh and the Maldives. These findings emphasize the importance of context-specific interventions targeting LBW to reduce child malnutrition in South Asia, while taking the observational design and cross-country variability into consideration.
- 21 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0358877
Open AccessExploring the association between low birth weight and different forms of child malnutrition: A multi-country propensity score matching analysis in South Asia
This study investigated the association between low birth weight (LBW) and various forms of child malnutrition across five South Asian countries (Bangladesh, India, Pakistan, Nepal, and the Maldives). Data from the most recent demographic and health surveys were analyzed. Propensity score matching was applied to evaluate the association between LBW and five forms of child malnutrition: stunting, wasting, underweight, at least one form of child malnutrition (AOFOCM), and multiple concurrent forms of child malnutrition (MCFOCM). Subgroup analyses were performed to assess variability in effects across the countries studied. Analysis of 147,332 complete cases revealed an overall LBW prevalence of 16.23%, with country-specific prevalences of 13.67% (Bangladesh), 16.32% (India), 18.97% (Pakistan), 11.94% (Nepal), and 12.86% (Maldives). Regression analyses of matched samples revealed significant associations between LBW and all five forms of malnutrition. Subgroup analyses also revealed a significant association between LBW and all five forms of malnutrition across the five countries, with the exception of wasting, for which no statistically significant association was observed in Bangladesh and the Maldives. These findings emphasize the importance of context-specific interventions targeting LBW to reduce child malnutrition in South Asia, while taking the observational design and cross-country variability into consideration.
- Open Access
- 9 January 2026
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (2) , 101508
Circulating Extracellular Vesicle Protein Biomarkers for the Early Detection of High-Grade Serous Ovarian Cancer
- 9 January 2026
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (2) , 101508
Open AccessCirculating Extracellular Vesicle Protein Biomarkers for the Early Detection of High-Grade Serous Ovarian Cancer
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data File 3 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Comparison of expression in hFTE with different EV treatments.
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data File 3 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Comparison of expression in hFTE with different EV treatments.
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
GO Biological pathways upregulated by FT240 EVs.
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
GO Biological pathways upregulated by FT240 EVs.
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Figure 7 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Validation of 1-day and 14-day treatment transcriptomics data using IHC. A, Left, CCL2 transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 1 day. Right, IHC staining for upregulated CCL2 in FTE from three individual patients. B, Left, FLNA transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 1 day. Right, IHC staining for downregulated FLNA in FTE from three individual patients. C, Left, VCAM1 transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 1 day. Right, IHC staining for upregulated VCAM1 in FTE from three individual patients. D, Left, TPI1 transcript expression in OVCAR3-, FT240-, PBS-treated secretory cells after 1 day. Right, IHC staining for downregulated protein TPI1 in FTE from three individual patients. E, Left, TXNIP transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 14 days. Right, IHC staining for downregulated TXNIP in FTE from three individual patients. F, Left, VCAM1 transcript expression in OVCAR3-, FT240-, and PBS-treated ciliated cells after 14 days. Right, IHC staining for upregulated VCAM1 in FTE from three individual patients. In all boxplots, each point represents normalized transcript abundance measured in a single segment. Scale bar, 20 μm; arrows indicate epithelium.
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 7 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Validation of 1-day and 14-day treatment transcriptomics data using IHC. A, Left, CCL2 transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 1 day. Right, IHC staining for upregulated CCL2 in FTE from three individual patients. B, Left, FLNA transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 1 day. Right, IHC staining for downregulated FLNA in FTE from three individual patients. C, Left, VCAM1 transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 1 day. Right, IHC staining for upregulated VCAM1 in FTE from three individual patients. D, Left, TPI1 transcript expression in OVCAR3-, FT240-, PBS-treated secretory cells after 1 day. Right, IHC staining for downregulated protein TPI1 in FTE from three individual patients. E, Left, TXNIP transcript expression in OVCAR3-, FT240-, and PBS-treated secretory cells after 14 days. Right, IHC staining for downregulated TXNIP in FTE from three individual patients. F, Left, VCAM1 transcript expression in OVCAR3-, FT240-, and PBS-treated ciliated cells after 14 days. Right, IHC staining for upregulated VCAM1 in FTE from three individual patients. In all boxplots, each point represents normalized transcript abundance measured in a single segment. Scale bar, 20 μm; arrows indicate epithelium.
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 15 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Key IFN-γ pathway genes are upregulated by OVCAR3 EV treatment.
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 15 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Key IFN-γ pathway genes are upregulated by OVCAR3 EV treatment.
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
EVs from OVCAR3 do not induce detectable DNA damage relative to controls in long term exposure.
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
EVs from OVCAR3 do not induce detectable DNA damage relative to controls in long term exposure.
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
GO Biological pathways downregulated by FT240 EVs.
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
GO Biological pathways downregulated by FT240 EVs.
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Figure 6 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Fallopian tube alters sEVs protein cargo after treatment with OVCAR3 EVs for 14 days. A, Diagram showing EV treatment of hFTE tissue and production of secondary-release EVs. B, Volcano plot showing proteomic changes in EVs derived from tissues treated with OVCAR3 EVs compared with PBS control. C, Volcano plot showing proteomics changes in EVs derived from tissues treated with FT240 EVs compared with PBS-treated controls. D, Venn diagram showing identification of 25 proteins exclusively upregulated by OVCAR3 EVs only. E, Venn diagram showing detection of DEPs not present in original OVCAR3 EVs in hFTE-derived EVs. F, GO biological pathway analysis of DEPs in hFTE-derived secondary-release EVs following stimulation with OVCAR3 EVs.
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 6 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
Fallopian tube alters sEVs protein cargo after treatment with OVCAR3 EVs for 14 days. A, Diagram showing EV treatment of hFTE tissue and production of secondary-release EVs. B, Volcano plot showing proteomic changes in EVs derived from tissues treated with OVCAR3 EVs compared with PBS control. C, Volcano plot showing proteomics changes in EVs derived from tissues treated with FT240 EVs compared with PBS-treated controls. D, Venn diagram showing identification of 25 proteins exclusively upregulated by OVCAR3 EVs only. E, Venn diagram showing detection of DEPs not present in original OVCAR3 EVs in hFTE-derived EVs. F, GO biological pathway analysis of DEPs in hFTE-derived secondary-release EVs following stimulation with OVCAR3 EVs.
- Open Access
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
PAX2 expression is downregulated by OVCAR3 EVs
- 4 August 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles
PAX2 expression is downregulated by OVCAR3 EVs